Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

ILRI publish new studies on MERS coronavirus
Camel in the desert
The similarity between MERS found in camels and in humans, suggests that camels may provide a primary source of infection of humans.

Hopes that new research will help hasten knowledge and control of MERS

The International Livestock Research Institute (ILRI) has published two new papers on MERS coronavirus and camels in Eastern Africa.

MERS was first discovered in a Saudi Arabian patient in 2012. It is a severe respiratory disease that causes cough, fever, shortness of breath and can lead to pneumonia and kidney failure. There is currently no cure or vaccine for MERS.  Since July 23, 2014, the infection has spread to over 800 people, killing almost 300. According to the US Centres for Disease Control, nearly all of the reported cases have been linked to the Arabian Peninsula.

Previous studies of the disease have found that Arabian camels can harbour the coronavirus that causes MERS.  ILRI say that the similarity between MERS found in camels and in humans, suggests that camels may provide a primary source of infection of humans.

Two new papers on MERS have now been published in the science journal Emerging Infectious Diseases.  In the studies, researchers from the ILRI and Kenyan partners explored the prevalence of antibodies to the MERS virus in camels in Kenya.

The first study proposed that young camels may spread the virus in camel populations and that MERS-CoV infections escalate when camel population density increases.

In the second study, a 30-year-collection of samples from East-African camels were tested for MERS coronavirus antibodies.  In total, 84 per cent of all camels tested positive, a finding that supports conclusions from previous studies.

In summary, the combination of a high-population density of camels with
nomadic camel farming - along with the presence of young camels who are susceptible to the virus - could increase the overall levels of the virus in regional camel populations. It may also increase the chance of the virus transmitting to humans.

The World Health Organisation (WHO) and member states are now being urged to improve national policies that address infection and control, and then implement those policies in health care facilities and systems.

WHO's Emergence Committee say say that "critical investigations should be initiated and accelerated, vulnerable countries should be supported, and better communications should be embraced to strengthen collaboration between all parties fighting the outbreak as well as to disseminate advice and warnings to the general public."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.